NEW YORK (GenomeWeb) – Empire Genomics said today it has tapped Quadpharma to manufacture analyte-specific reagents using current good manufacturing principles for its clients in the research, clinical, and pharmaceutical industries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.